Diana Taxiera, SVP and CFO of Narragansett Bancorp, Inc., filed a Form 3 initial statement of beneficial ownership on November 2, 2026, disclosing holdings in the company's common stock.
Morgan Stanley Finance LLC filed a Free Writing Prospectus on November 2, 2026, for Preliminary Pricing Supplement No. 19,760, describing SPXFP Dual Directional Buffered Jump Securities due December 4, 2031, linked to the S&P 500 Futures Excess Return Index.
JPMorgan Chase Financial Company LLC filed a free writing prospectus on November 2, 2026, disclosing the summary terms of Auto Callable Contingent Interest Notes linked to the common stock of Freeport-McMoRan Inc., with a pricing date of November 5, 2026, and a maturity date …
Morgan Stanley Finance LLC filed a Free Writing Prospectus to Preliminary Pricing Supplement No. 19,785 on November 2, 2026, for a structured note offering linked to the worst-performing of three equity indexes, maturing December 5, 2029.
Morgan Stanley Finance LLC filed a Free Writing Prospectus to Preliminary Pricing Supplement No. 19,719 on November 2, 2026, for a structured note called the Worst-of INDU and SPX Trigger PLUS due December 4, 2031.
MongoDB, Inc. director Dwight A. Merriman filed a Form 144 on November 2, 2026, notifying the SEC of a proposed sale of 19,275 shares of MongoDB common stock on NASDAQ:MDB, with an aggregate market value of approximately $6,701,335.07 across three tranches.
A Form 144 notice of proposed sale was filed on November 2, 2026, by Natascha Viljoen, an officer and director of Newmont Corp /DE/, indicating a plan to sell 3,882 shares of Newmont common stock through Fidelity Brokerage Services LLC.
Hayward Holdings, Inc. officer Susan M. Canning filed a Form 144 notice on November 2, 2026, disclosing a proposed sale of 2,500 shares of common stock on NYSE.
Vesta Real Estate Corporation Chief Legal Counsel Alejandro Pucheu Romero filed a Form 4 on November 2, 2026, disclosing the sale of 57,650 ordinary shares on October 30, 2026.
Suresh K. Durgam, a newly appointed director at Helus Pharma Inc., filed a Form 3 Initial Statement of Beneficial Ownership with the SEC on November 2, 2026, disclosing no securities beneficially owned as of the October 16, 2026 triggering event.